Systemic therapy for pretreated advanced biliary tract cancer: past developments and recent advancesNaohiro Okano, Shuichi Hironaka, Cody Eslinger et al.|Japanese Journal of Clinical Oncology|2025Cited by 1
Time Toxicity in Patients With Advanced Biliary Tract Cancer Receiving Gemcitabine Plus Cisplatin With or Without DurvalumabN. Okano, Mitesh J. Borad, Angelo Pirozzi et al.|JCO oncology advances.|2026Cited by 0